FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/03/082352 [Registered on: 17/03/2025] Trial Registered Prospectively
Last Modified On: 13/02/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Use of Kantakaryadi arka in allergic bronchitis  
Scientific Title of Study   A randomized controlled clinical trial to evaluate the efficacy of kantakaryadi arka in allergic bronchitis (Vataja Kasa) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Digvijay Singh 
Designation  PG Scholar 
Affiliation  Parul Institute of Ayurved 
Address  Room 204 Department of Kaumarbhritya Parul Institute of Ayurved Parul University Vadodara Gujarat 391760 India

Vadodara
GUJARAT
391760
India 
Phone  8708267035  
Fax    
Email  sdigvijay942@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kavya Mohan 
Designation  Associate Professor 
Affiliation  Parul Institute of Ayurved 
Address  Room 204 Department of Kaumarbhritya Parul Institute of Ayurved Parul University Vadodara Gujarat 391760 India

Vadodara
GUJARAT
391760
India 
Phone  9745727376  
Fax    
Email  kavya.thannickel@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Kavya Mohan 
Designation  Associate Professor 
Affiliation  Parul Institute of Ayurved 
Address  Room 204 Department of Kaumarbhritya Parul Institute of Ayurved Parul University Vadodara Gujarat 391760 India

Vadodara
GUJARAT
391760
India 
Phone  9745727376  
Fax    
Email  kavya.thannickel@gmail.com  
 
Source of Monetary or Material Support  
Parul University Limda Vadodara Gujarat India 391760 
 
Primary Sponsor  
Name  Parul Institute of Ayurved 
Address  Parul Institute of Ayurved Parul University At post Limda Waghodia Vadodara Gujarat India 391760  
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Digvijay Singh  PARUL AYURVED HOSPITAL  OPD No.103, Department of Kaumarbhritya,Parul University, Limda, Tal. waghodia, Vadodara, 391760
Vadodara
GUJARAT 
8708267035

sdigvijay942@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:J393||Upper respiratory tract hypersensitivity reaction, site unspecified. Ayurveda Condition: Kasah,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: Kantakaryadi Arka, Reference: Arka Prakasha, Route: Oral, Dosage Form: Arka, Dose: 12(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 7 Days, anupAna/sahapAna: Yes(details: Warm Water), Additional Information: -
2Comparator Arm (Non Ayurveda)-Cetrizine Syrup10 mg in 2 divided doses after food
 
Inclusion Criteria  
Age From  5.00 Year(s)
Age To  12.00 Year(s)
Gender  Both 
Details  Age group between 5yrs to 12yrs.
Patients of either gender will be included.
Patients of Vataja kasa with symptoms like Shushka Kasa (dry cough), Swarbheda (hoarseness of voice), Shirashool (headache), Parshvashool and Urashool (pain in flank and chest region), Shushka mukha and gala (dryness of mouth and throat irritation)

 
 
ExclusionCriteria 
Details  All types of Kasa except Vataja Kasa lakshana will be excluded.
Pneumonia, Juvenile DM, Tuberculosis, Asthma should be excluded.
Cough with expectoration along with fever
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   An Open list of random numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Improvement in episodes of cough dry  Day 1 Day 7 Day 14 
 
Secondary Outcome  
Outcome  TimePoints 
Improvement in cough Symptom Score  Day 1 Day 7 Day 14 
 
Target Sample Size   Total Sample Size="80"
Sample Size from India="80" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2 
Date of First Enrollment (India)   18/03/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Allergic Bronchitis is prevailed childhood illness need to be handle with active combination of  immunemodulators and antitussive agents, in present trial kantakari Arka is the similar combination used for childhood allergic bronchitis  
Close